UK markets open in 6 hours 32 minutes

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
68.73+0.82 (+1.21%)
At close: 04:00PM EDT
69.00 +0.27 (+0.39%)
After hours: 07:49PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 202.93B
Enterprise value 225.91B
Trailing P/E 62.19
Forward P/E 18.02
PEG ratio (5-yr expected) 2.01
Price/sales (ttm)4.62
Price/book (mrq)5.49
Enterprise value/revenue 5.09
Enterprise value/EBITDA 24.87

Trading information

Stock price history

Beta (5Y monthly) 0.17
52-week change 33.87%
S&P500 52-week change 3-13.21%
52-week high 372.12
52-week low 352.65
50-day moving average 366.68
200-day moving average 364.25

Share statistics

Avg vol (3-month) 35.09M
Avg vol (10-day) 34.83M
Shares outstanding 53.1B
Implied shares outstanding 6N/A
Float 818.61B
% held by insiders 10.05%
% held by institutions 117.67%
Shares short (14 Mar 2023) 43.12M
Short ratio (14 Mar 2023) 40.73
Short % of float (14 Mar 2023) 4N/A
Short % of shares outstanding (14 Mar 2023) 40.10%
Shares short (prior month 14 Feb 2023) 42.7M

Dividends & splits

Forward annual dividend rate 41.45
Forward annual dividend yield 42.16%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 34.27%
5-year average dividend yield 42.86
Payout ratio 4137.44%
Dividend date 326 Mar 2023
Ex-dividend date 422 Feb 2023
Last split factor 22:1
Last split date 326 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 7.41%
Operating margin (ttm)20.21%

Management effectiveness

Return on assets (ttm)5.55%
Return on equity (ttm)8.63%

Income statement

Revenue (ttm)44.35B
Revenue per share (ttm)2.38
Quarterly revenue growth (yoy)-6.70%
Gross profit (ttm)35.73B
Net income avi to common (ttm)3.29B
Diluted EPS (ttm)1.07
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.24B
Total cash per share (mrq)0.33
Total debt (mrq)31.14B
Total debt/equity (mrq)84.02
Current ratio (mrq)0.86
Book value per share (mrq)1.98

Cash flow statement

Operating cash flow (ttm)9.81B
Levered free cash flow (ttm)12.36B